Among the more novel genes we uncovered in our analysis (amplified in 4 of 10 metastatic tumors analyzed) was the neurotrophin receptor NTRK1, a tyrosine kinase growth factor receptor. The gene discussed is NTRK1; the disease is metastatic neoplasm.